The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice

Documenti analoghi

• Lack of endogenous cholecystokinin promotes cholelithogenesis in mice
  di: Wang, Helen H., et al.
  Pubblicazione: (2015)
• Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones
  di: Wang, Helen H., et al.
  Pubblicazione: (2019)
• Activation of Estrogen Receptor G Protein–Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice
  di: Wang, Helen H., et al.
  Pubblicazione: (2020)
• Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between celiac disease and cholesterol gallstone disease
  di: Wang, Helen H., et al.
  Pubblicazione: (2017)
• Transgenic Overexpression of Abcb11 Enhances Biliary Bile Salt Outputs, But Does Not Affect Cholesterol Cholelithogenesis in Mice
  di: Wang, Helen H., et al.
  Pubblicazione: (2010)